Skip to content

Examining the Effects of a Job Entry Intervention

Examining the Effects of a Job Entry Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04771338
Acronym
IMPRESSIVE
Enrollment
34
Registered
2021-02-25
Start date
2019-09-01
Completion date
2023-07-26
Last updated
2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ASD, Autism, Autism Spectrum Disorder

Keywords

Autism, ASD, Job reentry, Employment intervention, Virtual reality, VR

Brief summary

The current study will examine the efficacy of a virtual reality (VR) intervention as well as a newly developed Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE) with adolescents diagnosed with autism spectrum disorder.

Detailed description

The current study will examine the efficacy of a virtual reality (VR) intervention entitled IMPRoving Expression of Skills and Strengths In Interviewing in a Virtual Environment (IMPRESSIVE) which targets social competency skills needed for successful job interviewing. Specifically, 2 VR tools are utilized in the IMPRESSIVE intervention. The first tool is VR-Job Interview Training, a VR program which offers the opportunity for repeated practice with a virtual human interviewer. Preliminary evidence suggests that the VRprogram is successful in adults with ASD and schizophrenia in improving interview abilities. However, the efficacy of it has not been evaluated in adolescents with ASD. This represents a significant void in our knowledge, as we do not know whether this program is effective for youth. In addition to VR training, a newly developed tool is included in the currently proposed intervention: the Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE). KF-STRIDE is focused on improving the ability to express personal strengths during the job interview, a skill that is not taught with VR training. The proposed IMPRESSIVE intervention, which combines the learning of 2 critical abilities (social skills and strength identification), has never been examined in individuals with ASD. Thus, the current proposal will be the first to examine the efficacy of these 2 combined tools in this at-risk population.

Interventions

BEHAVIORALVR-JIT/KF-STRIDE

Treatment group will receive 12 sessions of job interview training protocol.

Sponsors

Kessler Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Virtual Reality Job Interview Training & character strength training (KF-STRIDE)

Eligibility

Sex/Gender
ALL
Age
15 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnoses of ASD * or am a typically developing adolescent * Able to speak and read English fluently

Exclusion criteria

* History of stroke, traumatic brain injury, or any other neurological injury or disease * History of significant psychiatric illness (bipolar, schizophrenia or psychosis) * Uncontrolled seizures * Any other unstable medical complications

Design outcomes

Primary

MeasureTime frameDescription
Mock Job Interview Change8 weeksMock Job Interview skills will be assessed by having blinded raters trained to assess job interviews scoring participants across a number of domains including expressing personal strengths and sounding professional. This rating scheme has been used in previous research (Smith et al., 2014; 2015),

Secondary

MeasureTime frameDescription
Self-reported job interview skills8 weeksQuestionnaire to assess self-perceived skills
self-reported job interview anxiety8 weeksQuestionnaire to assess self-perceived anxiety
Employment readiness8 weeksQuestionnaire to assess self-perceived employment readiness
Job Search Behavior8 weeksQuestionnaire to assess self-perceived job search behaviors

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026